Q3 2023 Aytu Biopharma Inc Earnings Call Transcript
Greetings. Welcome to the Aytu BioPharma fiscal 2023 Q3 results conference call. (Operator Instructions) Please note this conference is being recorded.
I'll now turn the conference over to your host, Roger Weiss. You may begin.
Good afternoon, everyone, and thank you for joining us for the Aytu BioPharma's third-quarter fiscal year 2023 financial results conference call for the period ending March 31, 2023. Joining us on today's call is Aytu's CEO, Josh Disbrow; and the company's Chief Financial Officer, Mark Oki. At the conclusion of today's prepared remarks, we will open the call for a question-and-answer session.
I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the earnings press release issued earlier today.
Finally, I'd like to call to your attention to the customary Safe Harbor disclosure regarding forward-looking information. The conference call today will contain
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |